Khalda Fadlalla

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Novel sulindac derivatives for colorectal cancer chemoprevention that target cGMP phosphodiesterases to suppress Wnt/β-catenin transcriptional activity”.

Novel sulindac derivatives for colorectal cancer chemoprevention that target cGMP phosphodiesterases to suppress Wnt/β-catenin transcriptional activity

Cancer Insight(2023)10.58567/ci02020003

N/A

0DataRank · unranked

2 citations

Peyton Johnson, Khalda Fadlalla, Austin Moore, Chung-Hui Huang, Kristy Berry +6 more

Novel sulindac derivatives for colorectal cancer chemoprevention that target cGMP phosphodiesterases to suppress Wnt/β-catenin transcriptional activity

Cancer Insight(2023)10.58567/ci03010003

N/A

0DataRank · unranked

1 citations

Peyton Johnson, Khalda Fadlalla, Austin Moore, Chung-Hui Huang, Kristy Berry +6 more

Targeting phosphodiesterase 10 unleashes antitumor immunity by inhibiting the RAS-MAPK signaling in cancer cells and myeloid-derived suppressor cells 3553

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1344

N/A

0DataRank · unranked

0 citations

Ogacheko Okoko, Xin Wang, Ye Yan, Khalda Fadlalla, Xi Chen +6 more